Asthma can be a manageable condition, but confidential enquiries into hundreds of asthma deaths in the UK have revealed sobering lessons. These reports, which informed the BTS/SIGN (British Thoracic Society/Scottish Intercollegiate Guidelines Network) guidelines, show that most fatalities are preventable and often occur before a patient even reaches the hospital.
Understanding the triad of factors that contribute to these deaths—disease severity, gaps in medical care, and patient behaviour—is crucial for both healthcare professionals and patients.
1. The Disease Factor: Severity and Suddenness
While chronically severe asthma is the background for most fatal attacks, it’s a dangerous misconception that only the severely ill are at risk. A minority of deaths occurred suddenly in patients with mild or moderate asthma.
The takeaway: All asthma should be taken seriously and every patient needs a written action plan.
2. Gaps in Medical Management
A significant number of deaths were linked to inadequate treatment and monitoring. This highlights several critical issues:
- Inadequate Steroid Use: Many patients who died received inadequate treatment with inhaled corticosteroids (ICS) or oral steroids. ICS is the cornerstone of long-term control and its underuse leaves the airways chronically inflamed and vulnerable.
- Over-reliance on Relievers (SABAs): Heavy or increasing use of short-acting beta-agonists (SABAs)—the “blue reliever inhalers”—was a major red flag. The NRAD report (National Review of Asthma Deaths) suggested that prescribing more than 12 SABA inhalers a year should immediately trigger a full review of a patient’s management. Excessive SABA use often means control is poor and should be replaced with better preventer therapy.
- Poor Monitoring and Follow-up: A lack of objective monitoring and inadequate follow-up by healthcare providers contributed to deaths. Furthermore, the risk of death is increased within one month of discharge from hospital following an acute attack, making follow-up in primary care essential.
- Medication Dangers: Inappropriate prescription of beta blockers and non-steroidal anti-inflammatory drugs (NSAIDs) continues to cause fatalities. All asthma patients must be screened for past reactions to these drugs.
3. The Behavioural and Psychosocial Link
Perhaps the most challenging factor is the link between asthma death and a patient’s behavioural or psychosocial status, which was recorded in the majority of fatalities. High-risk behaviours include:
- Non-adherence: Failure to take prescribed medications or to monitor symptoms.
- Disengagement: Repeatedly failing to attend appointments or frequent self-discharge from the hospital.
- Psychological Distress: Conditions like psychosis, depression, deliberate self-harm, and major stress (marital, legal, domestic) significantly increase the risk.
- Substance Abuse and Lifestyle: Alcohol or drug abuse, and obesity are also documented risk factors.
The takeaway for patients: Be honest with your doctor about your medication use and any major stressors or mental health concerns you are experiencing. These issues are directly related to your physical risk.
Identifying and Protecting the High-Risk Patient
Healthcare professionals must be vigilant in identifying patients who combine severe asthma with adverse psychosocial factors. A patient is considered high-risk if they have one or more indicators of severe asthma and one or more adverse behavioural features.
| Severe Asthma Indicators (The Physical Risk) | Adverse Behavioural/Psychosocial Features (The Fatal Trigger) |
| Previous near-fatal asthma (e.g., ventilation). | Non-adherence with treatment or monitoring. |
| Admission for asthma in the last year. | Failure to attend appointments. |
| Requiring three or more classes of asthma medication. | Psychosis, depression, or deliberate self-harm. |
| Heavy use of beta agonists (SABA). | Severe domestic, marital, or legal stress. |
Crucial Actions for Risk Reduction:
- Specialist Supervision: Patients who have experienced a near-fatal asthma attack must be kept under specialist supervision indefinitely.
- Mandatory Follow-Up: A respiratory specialist should follow up patients admitted with a severe attack for at least one year after the admission.
By recognizing that asthma management extends beyond simple prescriptions to include psychosocial support and vigilant monitoring, we can ensure that these deadly lessons lead to safer, healthier outcomes for all asthma patients.
Further Reading and Related Guidance
BTS/NICE/SIGN Joint Guideline on Asthma: Diagnosis, Monitoring and Chronic Asthma Management (NG245) Link: https://www.nice.org.uk/guidance/ng245
Asthma pathway (BTS, NICE, SIGN) Link: https://www.nice.org.uk/guidance/ng244
Asthma + Lung UK (Charity) Resources on NRAD Link: https://www.asthmaandlung.org.uk/
Dr. Kunal Varma Bheecarry, MD is a GMC registered substantive Consultant Physician in the UK, specializing in Internal Medicine. With more than 15 years of experience on the clinical frontlines in both General Internal Medicine and Acute Medicine, he is passionate about translating complex medical topics, common problems and clinical guidelines into clear, actionable knowledge for healthcare professionals and patients alike. Every article is written and rigorously reviewed by him and other registered medical professionals to ensure clinical accuracy, guideline compliance, evidence-based reliability, authoritativeness and trustworthiness.
Disclaimer: All content is purely educational and does not constitute personal medical advice. It is not a substitute for professional clinical advice and readers must consult their own primary team. All views and interpretations are mine and not related to the work place.